- Home
- BRY vs NKTR Comparison
BRY vs NKTR Comparison
Compare BRY & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRY | NKTR |
|---|---|---|
| Founded | 1909 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.1M | 1.1B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | BRY | NKTR |
|---|---|---|
| Price | $3.25 | $44.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $4.00 | ★ $111.83 |
| AVG Volume (30 Days) | 572.1K | ★ 787.8K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $730,290,000.00 | $62,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.11 | $6.48 |
| 52 Week High | $5.09 | $66.92 |
Technical Indicators
Market Signals| Indicator | BRY | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 40.58 | 35.01 |
| Support Level | $3.19 | $50.49 |
| Resistance Level | $3.50 | $59.23 |
| Average True Range (ATR) | 0.08 | 4.34 |
| MACD | -0.01 | -1.34 |
| Stochastic Oscillator | 16.13 | 2.62 |
Price Performance
Historical ComparisonAbout BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.